Funders · Entity Annotation Prototype (beta)

1articles mentioning funders

1funder mentions

1distinct funders extracted

0%of mentions human-reviewed

Active filtersEntity: Mass General Brigham IRB ×

Mass General Brigham IRB

This funder is selected. Its supporting articles are shown below.

Mass General Brigham IRB1

Articles mentioning Mass General Brigham IRB

1 articles · page 1 of 1

380 Cutaneous eruptions associated with lifileucel, a first-in-class tumor-infiltrating lymphocyte therapy, and interleukin-2 in individuals with metastatic melanoma: a retrospective prognostic analysis

jitc · abstract · 2025-11-04 · 1 matching annotations

78.6%

Mass General Brigham IRB lifileucel lifileucel-associated pembrolizumab Ripretinib Dabrafenib

…matol.2019.10.006Ethics Approval This study was approved by the Mass General Brigham IRB, under Protocol #: 2020P002307.Consent Written informed consent…

Browse funders

Mass General Brigham IRB

Articles mentioning Mass General Brigham IRB

380 Cutaneous eruptions associated with lifileucel, a first-in-class tumor-infiltrating lymphocyte therapy, and interleukin-2 in individuals with metastatic melanoma: a retrospective prognostic analysis